Urology
Volume 61, Issue 1 , Pages 23-29 , January 2003

Management of small renal tumors with radiofrequency ablation

  • Ganesh V Raj

      Affiliations

    • Divisions of Urology, Duke University Medical Center, Durham, North Carolina, USA
    • ,
  • Donal J Reddan

      Affiliations

    • Divisions of Nephrology, Duke University Medical Center, Durham, North Carolina, USA
    • ,
  • Michael B Hoey

      Affiliations

    • Department of Physiology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA
    • ,
  • Thomas J Polascik

      Affiliations

    • Divisions of Urology, Duke University Medical Center, Durham, North Carolina, USA
    • Corresponding Author InformationReprint requests: Thomas J. Polascik, M.D., Division of Urology, Box 2922, Duke University Medical Center, Central Medical Park, 2609 North Duke Street, Suite 102, Durham, NC 27704, USA

Received 24 May 2001 ,Accepted 20 May 2002.

References 

  1. Chow WH, Devesa SS, Warren JL, et al.  Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628–1631
  2. Greenlee RJ, Murray T, Bolden S, et al.  Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33
  3. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma—age and stage characterization and clinical implications (study of 1092 patients (1982–1997)). Urology. 2000;56:58–62
  4. Novick AC. Management of the incidentally detected solid renal mass. Semin Nephrol. 1994;14:519–522
  5. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51:203–205
  6. Novick AC. Nephron-sparing surgery for renal cell carcinoma. Br J Urol. 1998;82:321–324
  7. Pantunck AJ, Zisman A, Rauch MK, et al.  Incidental renal tumors. Urology. 2000;56:190–196
  8. Hafez KS, Fergany AF, Novick AC. Nephron-sparing surgery for localized renal cell carcinoma (impact of tumor size on patient survival, tumor recurrence and TNM staging). J Urol. 1999;162:1930–1933
  9. Sweeney JP, Thornhill JA, Grainger R, et al.  Incidentally detected renal cell carcinoma (pathological features, survival trends and implications for treatment). Br J Urol. 1996;78:351–353
  10. Novick AC. Radical nephrectomy and nephron-sparing surgery for localized renal cell carcinoma. In:  Bukowski RM,  Novick AC editor. Renal Cell Carcinoma: Molecular Biology, Immunology, and Clinical Management. Totowa, New Jersey: Humana Press; 2000;p. 163–172
  11. Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney (10-year followup). J Urol. 1999;161:33–35
  12. Licht MR, Novick AC. Nephron-sparing surgery for renal cell carcinoma. J Urol. 1993;149:1–8
  13. Licht MR, Novick AC, Goormastic M. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol. 1994;152:39–42
  14. Lee CT, Katz J, Shi W, et al.  Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol. 2000;163:730–736
  15. Cadeddu JA, Ono Y, Clayman RV, et al.  Laparoscopic nephrectomy for renal cell cancer (evaluation of efficacy and safety—a multicenter experience). Urology. 1998;52:773–777
  16. Janetschek G, Daffner P, Peschel R, et al.  Laparoscopic nephron sparing surgery for small renal cell carcinoma. J Urol. 1998;159:1152–1155
  17. Merkle EM, Shonk JR, Duerk JL, et al.  MR-guided RF thermal ablation of the kidney in a porcine model. AJR Am J Roentgenol. 1999;173:645–651
  18. Gill IS, Novick AC. Renal cryosurgery. Urology. 1999;54:215–219
  19. McGovern FJ, Wood BJ, Goldberg N, et al.  Radiofrequency ablation of renal cell carcinoma via image guided needle electrodes. J Urol. 1998;161:599–600
  20. Polascik TJ, Meng MV, Epstein JI, et al.  Intraoperative sonography for the evaluation and management of renal tumors (experience with 100 patients). J Urol. 1995;154:1676–1680
  21. Calkins H, Lanberg J, Sousa J, et al.  Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients (abbreviated therapeutic approach to Wolff-Parkinson-White syndrome). Circulation. 1992;85:1337–1343
  22. Hoey MF, Mulier PM, Shake JG. Intramural ablations using screw tip catheter and saline electrode produces predictable lesion sizes. Circulation. 1995;92:794–795
  23. Curley SA, Izzo F, Delrio P, et al.  Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies (results in 123 patients). Ann Surg. 1999;230:1–8
  24. Hoey MF, Mulier PM, Leveillee RJ, et al.  Transurethral prostate ablation with saline electrode allows controlled production of larger lesions than conventional methods. J Endourol. 1997;11:279–284
  25. McGahan JP, Browning PD, Brock JM, et al.  Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990;25:267–270
  26. Dixon CM. Transurethral needle ablation for the treatment of benign prostatic hyperplasia. Urol Clin North Am. 1995;22:441–444
  27. Djavan B, Zlotta AR, Susani M, et al.  Transperineal radiofrequency interstitial tumor ablation of the prostate (correlation of magnetic resonance imaging with histopathological examination). Urology. 1997;50:986–992
  28. Lele PP: Thresholds and mechanisms of ultrasonic damage to organized animal tissues, in Proceedings of the Symposium on Biological Effects and Characterizations of Ultrasound Sources. DHEW Publication FDA 78-8048. Rockville, Maryland, 1977, pp 224–239
  29. Leveillee RJ, Hoey MF, Hulbert JC, et al.  Enhanced radiofrequency ablation of canine prostate utilizing a liquid conductor (the virtual electrode). J Endourol. 1996;10:5–11
  30. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol. 1948;1:93–122
  31. Pearson AS, Izzo F, Fleming RY, et al.  Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592–599
  32. Schulman CC, Vandenbossche M. Transurethral thermotherapy by radiofrequency at various temperatures in benign prostatic hypertrophy (clinical experience with Thermex II Direx). J Urol (Paris). 1993;99:344–348
  33. Zlotta AR, Wildschutz T, Raviv G, et al.  Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer (ex vivo and in vivo experience). J Endourol. 1997;11:251–258
  34. Gill IS, Hsu TH, Fox RL, et al.  Laparoscopic and percutaneous radiofrequency ablation of the kidney (acute and chronic porcine study). Urology. 2000;56:197–200
  35. Hsu THS, Fidler ME, Gill IS. Radiofrequency ablation of the kidney (acute and chronic histology in porcine model). Urology. 2001;56:873–875
  36. Polascik TJ, Hamper U, Lee BR, et al.  Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy (preliminary report of a new technology). Urology. 1999;53:465–472
  37. Patel VR, Leveillee RJ, Hoey MF, et al.  Radiofrequency ablation of rabbit kidney using liquid electrode (acute and chronic observations). J Endourol. 2000;14:155–159
  38. Hisazumi H, Nakajima K. Eight-MHz RF-hyperthermia for advanced urological malignancies. Jpn J Cancer Chemother. 1986;13:1381–1386
  39. Nakajima K, Hisazumi H, Nakashima T, et al.  A combined treatment of interferon-alpha, 8 MHz radiofrequency hyperthermia and/or irradiation in a patient with advanced renal cancer. Acta Urol Jap. 1987;33:1851–1856
  40. Gervais DA, McGovern FJ, Wood BJ, et al.  Radiofrequency ablation of renal cell carcinoma (early clinical experience). Radiology. 2000;217:665–672
  41. Walther MM, Shawker TH, Libutti SK, et al.  Phase 2 study of radiofrequency interstitial tissue ablation of localized renal tumors. J Urol. 2000;163:1424–1427
  42. Leveillee RJ, Civanlos F, Wong C, et al.  Saline augmented radiofrequency ablation of human renal neoplasms alters the staining pattern and interpretation of cell type (a phase I study). J Urol. 2001;165:124–125
  43. Crowley JD, Shelton J, Iverson AJ, et al.  Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue (acute and chronic effects in an animal model). Urology. 2001;57:976–980
  44. Djavan B, Partin AW, Hoey MF, et al.  Transurethral radiofrequency prostate ablation using a novel saline liquid electrode (the virtual electrode). Urology. 2000;55:13–16
  45. Fergany AF, Hafez KS, Novick AC, et al.  Long-term results of nephron-sparing surgery for localized renal cell carcinoma (10-year followup). J Urol. 2000;163:442–447
  46. Gazelle GS, Goldberg SN, Solbiati L, et al.  Tumor ablation with radio-frequency energy. Radiology. 2000;217:633–646
  47. Delvecchio FC, Preminger GM. Renal surgery in the new millennium. Urol Clin North Am. 2000;27:801

☆ T. J. Polascik receives laboratory funding from U.S. Surgical Company; G. V. Raj receives funding from the National Kidney Foundation of North Carolina.

PII: S0090-4295(02)01850-2

Urology
Volume 61, Issue 1 , Pages 23-29 , January 2003

Article Tools

* Image Usage & Resolution